nplate
Showing 1 - 25 of 28
Hematologic Malignancies Trial in Minneapolis (Romiplostim)
Completed
- Hematologic Malignancies
-
Minneapolis, MinnesotaUniversity of Minnesota Masonic Cancer Center
Jun 5, 2021
Non-Hodgkin Lymphoma Trial in Milano (Romiplostim)
Completed
- Non-Hodgkin Lymphoma
-
Milano, ItalyDip. Oncoematologia - Fondazione Centro San Raffaele del Monte T
Aug 10, 2022
Severe Aplastic Anemia (SAA) Trial (Romiplostim, Antithymocyte Globulin, Cyclosporine A)
Not yet recruiting
- Severe Aplastic Anemia (SAA)
- Romiplostim
- +2 more
- (no location specified)
Sep 2, 2022
Pharmacodynamics, Pharmacokinetics, Bioequivalence Trial in Yaroslavl (GP40141, Nplate)
Recruiting
- Pharmacodynamics
- +2 more
- GP40141
- Nplate
-
Yaroslavl, Russian FederationYaroslavl Region "Clinical Hospital No. 3", ,, Mayakovskogo st.,
Dec 14, 2022
Idiopathic Thrombocytopenic Purpura Trial in Russian Federation (GNR-069, Nplate)
Recruiting
- Idiopathic Thrombocytopenic Purpura
- GNR-069
- Nplate
-
Irkutsk, Irkutsk Region, Russian Federation
- +17 more
Aug 3, 2022
Bone Marrow Failure Disorders, Aplastic Anemia, Thrombocytopenia Trial in Iowa City (Romiplostim)
Recruiting
- Bone Marrow Failure Disorders
- +4 more
-
Iowa City, IowaUniversity of Iowa Hospitals & Clinics
Jun 4, 2021
Thrombocytopenia in Patients With Wiskott-Aldrich Syndrome.
Completed
- Wiskott-Aldrich Syndrome
-
Moscow, Russian FederationDmitry Rogachev National Research Center of Pediatric Hematology
Dec 24, 2020
Idiopathic Thrombocytopenic Purpura Trial in Worldwide (Romiplostim)
Completed
- Idiopathic Thrombocytopenic Purpura
- Romiplostim
-
Anaheim, California
- +47 more
Sep 8, 2022
Wiskott-Aldrich Syndrome Trial in Moscow (Romiplostim, Eltrombopag)
Recruiting
- Wiskott-Aldrich Syndrome
-
Moscow, Russian FederationDmitry Rogachev National Research Center of Pediatric Hematology
May 4, 2020
Idiopathic Thrombocytopenic Purpura Trial (Romiplostim, Placebo)
Completed
- Idiopathic Thrombocytopenic Purpura
- Romiplostim
- Placebo
- (no location specified)
Dec 20, 2019
Chemo-induced Thrombocytopenia Trial in Worldwide (Romiplostim, Placebo)
Recruiting
- Chemotherapy-induced Thrombocytopenia
- Romiplostim
- Placebo
-
Jonesboro, Arkansas
- +107 more
Feb 1, 2023
Idiopathic Thrombocytopenic Purpura Trial in Russian Federation (GNR-069)
Enrolling by invitation
- Idiopathic Thrombocytopenic Purpura
- GNR-069
-
Irkutsk, Irkutsk Region, Russian Federation
- +12 more
Aug 5, 2022
Primary Immune Thrombocytopenia Trial in Shandong (QL0911, Placebo comparator)
Completed
- Primary Immune Thrombocytopenia
- QL0911
- Placebo comparator
-
Shandong, ChinaQilu Hospital of Shandong University
Nov 20, 2022
Immune Thrombocytopenia Trial in New York (Eltrombopag, Romiplostim, healthy controls)
Completed
- Immune Thrombocytopenia
- Eltrombopag
- +2 more
-
New York, New YorkWeill Cornell Medical College
Mar 15, 2019
Thrombocytopenia in Pediatric Subjects With Immune Idiopathic Thrombocytopenic Purpura ITP Trial in Worldwide (Romiplostim)
Completed
- Thrombocytopenia in Pediatric Subjects With Immune Idiopathic Thrombocytopenic Purpura ITP
- Romiplostim
-
Orange, California
- +30 more
Jan 7, 2020
Refractory Multiple Myeloma, Stage I Multiple Myeloma, Stage II Multiple Myeloma Trial in New York (romiplostim)
Terminated
- Refractory Multiple Myeloma
- +4 more
- romiplostim
-
New York, New YorkNYU Cancer Institute
Sep 13, 2018
Ovarian Cancer Trial in Germany (Standard chemo, Romiplostim, Placebos)
Terminated
- Ovarian Cancer
- Standard chemotherapy
- +2 more
-
Berlin, Germany
- +12 more
Feb 3, 2021
Hepatitis C Infection, Thrombocytopenia Trial in Los Angeles (biological, drug, other)
Terminated
- Hepatitis C Infection
- Thrombocytopenia
- romiplostim
- +4 more
-
Los Angeles, CaliforniaUSC/Norris Comprehensive Cancer Center
Apr 9, 2017
Idiopathic Thrombocytopenic Purpura, Thrombocytopenia, Thrombocytopenia in Pediatric Subjects With Immune (Idiopathic)
Completed
- Idiopathic Thrombocytopenic Purpura
- +5 more
- Romiplostim
- Placebo
-
Orange, California
- +32 more
Feb 7, 2017
Birth Defect, Spontaneous Abortions, Low Birth Weight Trial (Not applicable- observational study)
Terminated
- Birth Defect
- +2 more
- Not applicable- observational study
- (no location specified)
Dec 23, 2014
ITP Estimating Proportion Administering Romiplostim Correctly
Completed
- Immune Thrombocytopenic Purpura
-
Innsbruck, Austria
- +21 more
Dec 21, 2015
Thrombocytopenia, Idiopathic Thrombocytopenic Purpura Trial (Romiplostim)
Completed
- Thrombocytopenia
- Idiopathic Thrombocytopenic Purpura
- Romiplostim
- (no location specified)
Nov 25, 2013